Johnson & Johnson, Abbott Labs, and Philip Morris' Earnings: A Preview
- July 20th, 2023
- 546 views
On Thursday, July 20, three prominent companies are set to unveil their financial results:
Johnson & Johnson (NYSE: JNJ), a leading pharmaceutical and consumer goods company, will announce its second-quarter 2023 results before the market opens.
Analysts are projecting an EPS of $2.62 on revenue of $24.63 billion.
On Wednesday, $JNJ closed at $158.74, down $0.32 (-0.20%).
Abbott Laboratories (NYSE: ABT), a diversified healthcare company, will report its second-quarter 2023 financial results prior to the market opening.
The consensus estimate expects an EPS of $1.05 on revenue of $9.7 billion.
$ABT closed at $107.28 on Wednesday, reflecting a gain of $0.33 (+0.31%).
Philip Morris International Inc. (NYSE: PM), a leading tobacco company, will release its 2023 second-quarter and first-half results before the market opens.
Analysts forecast an EPS of $1.47 on revenue of $8.65 billion.
On Wednesday, $PM closed at $98.77, up $0.42 (+0.43%).
THIS IS NOT A RECOMMENDATION TO BUY OR SELL ANY SECURITY OR DIGITAL ASSET. Please consult with a professional investment advisor before purchasing or selling any securities viewed on or mentioned herein. (Read Full Disclaimer)
Post Your Comments
Want To Find Some News?
Recent Posts
-
FTC Takes Action to Prevent Anticompetitive Arrangement in Beretta, Ruger Deal
September 16th, 2026Why Opponent Preparation Matters for Post-Graduate Athletes
September 16th, 2026The Work Behind the Game: How Football Teams Prepare to Compete
September 15th, 2026NJCP Operates on a Prep Model Built Around a Full Season
September 14th, 2026Earnings Preview: High Tide, Kestra Medical, and RF Industries in Focus
September 12th, 2026
Member Login